The long term objective of this Academic Research Enhancement Award proposal is to elucidate the mechanism of outside-in signal transduction mediated by the platelet fibrinogen receptor, the integrin alphaIIb-beta3. Elucidation of the mechanism of outside- in signal transduction in human platelets is important basic research. This research is important not only because of the central role of platelets in cardiovascular disease but also because insight into the mechanism of outside-in signal transduction is of central importance to cell biology in general. Gaining insight into the molecular details of outside-in signal transduction in platelets may provide a rationale for the design of a pharmaceutical agent able to control at least some of the platelet behavior which contributes to development and progression of cardiovascular disease. The long-term objective of this proposal will be accomplished by characterizing the effects of a unique receptor activating peptide on platelet function. This receptor activating peptide appears to cause platelet aggregation by binding to alphaIIb and thereby eliciting a conformation change in the fibrinogen receptor which initiates a platelet activation signal transduction cascade that culminates in """"""""irreversible"""""""" platelet aggregation. The experiments described in this proposal are designed to reveal how binding of the receptor activating peptide to the receptor enables the previously inactive receptor to be able to bind fibrinogen and to determine if fibrinogen binding is necessary for subsequent signal transduction by the receptor or if subsequent signal transduction can occur in the absence of receptor crosslinking by fibrinogen or ligands. Hopefully, these experiments will reveal the type of intra-receptor subunit or inter-receptor interactions which initiate the outside-in signal transduction response in platelets.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
2R15HL056369-02
Application #
2613016
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1996-06-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
2000-05-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Memphis
Department
Microbiology/Immun/Virology
Type
Schools of Arts and Sciences
DUNS #
City
Memphis
State
TN
Country
United States
Zip Code
38152
Cho, M J; Liu, J; Pestina, T I et al. (2003) AlphaIIbbeta3-mediated outside-in signaling induced by the agonist peptide LSARLAF utilizes ADP and thromboxane A2 receptors to cause alpha-granule secretion by platelets. J Thromb Haemost 1:363-73
Cho, Moon J; Liu, Junling; Pestina, Tamara I et al. (2003) The roles of alpha IIb beta 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation. Blood 101:2646-51
Cho, Moon J; Pestina, Tamara I; Steward, Shirley A et al. (2002) The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP. Biochem Biophys Res Commun 292:916-21
Cho, Moon J; Pestina, Tamara I; Steward, Shirley A et al. (2002) Role of the Src family kinase Lyn in TxA2 production, adenosine diphosphate secretion, Akt phosphorylation, and irreversible aggregation in platelets stimulated with gamma-thrombin. Blood 99:2442-7
Derrick, J M; Shattil, S J; Poncz, M et al. (2001) Distinct domains of alphaIIbbeta3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIbbeta3 interacting peptide. Thromb Haemost 86:894-901
Smith, R A; Rooney, M M; Lord, S T et al. (2000) Evidence for new endothelial cell binding sites on fibrinogen. Thromb Haemost 84:819-25
Basani, R B; French, D L; Vilaire, G et al. (2000) A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3. Blood 95:180-8
Derrick, J M; Loudon, R G; Gartner, T K (1998) Peptide LSARLAF activates alpha(IIb)beta3 on resting platelets and causes resting platelet aggregate formation without platelet shape change. Thromb Res 89:31-40
Smith, R A; Mosesson, M W; Rooney, M M et al. (1997) The role of putative fibrinogen Aalpha-, Bbeta-, and GammaA-chain integrin binding sites in endothelial cell-mediated clot retraction. J Biol Chem 272:22080-5
Derrick, J M; Taylor, D B; Loudon, R G et al. (1997) The peptide LSARLAF causes platelet secretion and aggregation by directly activating the integrin alphaIIbbeta3. Biochem J 325 ( Pt 2):309-13